LAMINIL

Willowcroft Pharm Incorporated is a privately-held equine pharmaceutical company that develops innovative and effective treatments for horses. Our initial product, Laminil, is the first effective treatment for laminitis, which is the second leading cause of death in horses. Our next products will be similarly innovative and effective in treating common equine ailments... Laminil™ (cromolyn sodium) is a mast cell stabilizing drug that modulates the inflammatory response in equine laminitis... Every minute of every day, thousands of horses around the world endure the pain and suffering of laminitis. It takes the lives of tens of thousands of horses every year. It is the second leading medical cause of death. Yet, there has been no treatment for laminitis, until now. Laminil stops laminitis. It does not cure the disease. Laminil halts the inflammatory response and opens a window of opportunity for the horse to heal and recover. Our mission is to relieve the pain and suffering by making..

Primary location: Newberry United States